Top Buy
| Security | Buy | Sell | Buy (1W) ▲ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Amicus Therapeutics Inc. | 6 | 0 | 0 | 0 | €8.80 | €17.78 | 102.036% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €20.56 | - | - |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.39 | €3.70 | 166.955% |
| PTC Therapeutics Inc. | 15 | 8 | 0 | 1 | €33.80 | €41.51 | 22.818% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | €35.80 | €38.99 | 8.907% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 0 | 0 | €36.20 | €84.74 | 134.099% |
| United Therapeutics | 19 | 0 | 0 | 0 | €247.80 | €287.40 | 15.981% |
| Blueprint Medicines Corp | 2 | 0 | 0 | 0 | €94.28 | - | - |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 0 | 0 | €22.02 | €52.03 | 136.262% |
| Xencor Inc. | 10 | 1 | 0 | 0 | €21.60 | €32.58 | 50.828% |
| Charles River Labs Intl | 10 | 0 | 0 | 0 | €200.40 | €248.57 | 24.037% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €18.72 | €26.01 | 38.960% |
| Catalent Inc. | 1 | 0 | 0 | 0 | €49.71 | €55.00 | 10.653% |
| Repligen Corp. | 13 | 0 | 0 | 0 | €144.35 | €184.76 | 27.994% |
| Alnylam Pharmace. | 36 | 0 | 0 | 0 | €138.25 | €236.30 | 70.921% |
| Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | €4.35 | €4.62 | 6.236% |
| Iovance Biotherapeutics Inc. | 21 | 3 | 1 | 0 | €8.93 | €25.20 | 182.289% |
| Neurocrine Bioscience | 30 | 0 | 1 | 0 | €129.35 | €140.87 | 8.904% |
| Medpace Holdings Inc | 10 | 0 | 1 | 0 | €360.20 | €420.62 | 16.774% |
| Halozyme Therapeutics Inc. | 15 | 0 | 1 | 0 | €39.67 | €47.17 | 18.906% |